Recent News Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029 05/10/24 Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes 05/08/24 Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program 05/07/24 Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference 05/07/24 Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 04/30/24 Browse the press release archive